Can Risks Be Offset by the Prospect of Benefit in Trial Design?

American Journal of Bioethics Neuroscience 6 (1):61-62 (2015)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/21507740.2014.991852

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compass.A. S. Iltis - 2005 - Journal of Medical Ethics 31 (7):410-414.
A Defense of The-Risks-of-Daily-Life.Ariella Binik - 2017 - Kennedy Institute of Ethics Journal 27 (3):413-442.
Risk-Benefit Analysis: From a Logical Point of View. [REVIEW]Georg Spielthenner - 2012 - Journal of Bioethical Inquiry 9 (2):161-170.
The Risk-Escalation Model: A Principled Design Strategy for Early-Phase Trials.Spencer Phillips Hey & Jonathan Kimmelman - 2014 - Kennedy Institute of Ethics Journal 24 (2):121-139.
Statistical Power, the Belmont Report, and the Ethics of Clinical Trials.Sara H. Vollmer & George Howard - 2010 - Science and Engineering Ethics 16 (4):675-691.
The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods.D. L. C. Bernabe Rosemarie, J. M. W. van Thiel Ghislaine, A. M. Raaijmakers Jan & J. M. van Delden Johannes - 2012 - BMC Medical Ethics 13 (1):6.
Inherent risk and organisational design in european tort law.Willem H. van Boom - unknown
The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods. [REVIEW]Johannes J. M. Van Delden Rosemarie D. L. C. Bernabe, Ghislaine J. M. W. Van Thiel, Jan A. M. Raaijmakers - 2012 - BMC Medical Ethics 13 (1):6.
Reciprocity‐Based Reasons for Benefiting Research Participants: Most Fail, the Most Plausible is Problematic.Neema Sofaer - 2013 - Bioethics 28 (9):456-471.
Interpreting clinical trial results by deductive reasoning: In search of improved trial design.Sven Kurbel & Slobodan Mihaljević - 2017 - Bioessays 39 (10):1700103.
Ethical Considerations for Outcome‐adaptive Trial Designs: A Clinical Researcher's Perspective.Scott Brian Saxman - 2014 - Bioethics 29 (2):59-65.
The Merits of Procedure-Level Risk-Benefit Assessment.Anna Westra & Inez de Beaufort - 2011 - IRB: Ethics & Human Research 33 (5):7-13.
Ethical reflections on clinical trials with human tissue engineered products.L. Trommelmans, J. Selling & K. Dierickx - 2008 - Journal of Medical Ethics 34 (9):e1-e1.
Schemata, CONSORT, and the Salk Polio Vaccine Trial.Charles J. Kowalski & Adam J. Mrdjenovich - 2018 - Journal of Medicine and Philosophy 43 (1):64-82.
The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study.H. E. M. van Luijn - 2006 - Journal of Medical Ethics 32 (3):170-176.

Analytics

Added to PP
2018-06-22

Downloads
5 (#1,510,250)

6 months
1 (#1,510,037)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references